September 21, 2009 08:00 ET

WebMD Co-Founder Aims to Change the Way Drug Samples Are Dispensed With SampleMD

ROCHESTER, MI--(Marketwire - September 21, 2009) - Blake Whitney, former president and founding member of WebMD, announced the launch of SampleMD™ -- a new, downloadable virtual "drug sample cabinet" that allows doctors and staff to print or electronically send sample vouchers and co-pay coupons right to pharmacies directly from their desktops.

"With up to 40% of physicians no longer seeing drug reps, along with increasing compliance factors associated with distributing physical drug samples, doctors' offices are looking for a better way to help their patients get started on a brand drug," Whitney stated.

SampleMD intends to be that solution.

Doctors and health providers will download the SampleMD™ application right on to their desktops or access it through their Electronic Medical Records system to search, print or electronically dispense drug samples and co-pay coupons through a national network of pharmacies. This minimizes the need for physician offices to manage and store physical drug samples by offering a more convenient and efficient way to allocate, administer and report needed samples and co-pay savings to their patients.

Doctors can also review a branded drug's "formulary status" within the patients' insurance plan to determine what level the product is paid or reimbursement.

Unlike physical samples, SampleMD also provides on-going patient support through their automated communications and delivery of monthly co-pay savings to promote continued drug compliance for chronic conditions such as diabetes, heart disease and asthma.

SampleMD is owned by OPTIMIZERx Corporation (PINKSHEETS: OPRX), of which Mr. Whitney serves on the advisory committee. Principal development has been led by Dr. Nilesh Patel, PhD and faculty within Oakland University.

The company expects to beta launch SampleMD within thousands of physician offices in early 2010. For more information on SampleMD, go to

About OPTIMIZERx Corporation

OPTIMIZERx provides unique platforms to help patients better afford and comply to their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company's patient support website,, and its permanent subscriber base, continue to grow each month and is quickly becoming the preferred way to access branded prescription savings and support programs. Additionally, OPTIMIZERx has developed OFFERx™, ADHERxE™ and SampleMD™ to allow a more streamlined, effective way to create, promote and manage new trial, co-pay or adherence programs


This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact Information

  • Company Contact:
    David Harrell